ACTRN12618000781246已完成4 期
Inhaled corticosteroids for treating active lung disease in survivors of preterm birth
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 214
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 6 Years 至 12 Years（—）
- 性别
- All
入选标准
- •Preterm-born participants: Children aged 6-12 years who were born at less than or equal to 32 weeks gestation,
- •Healthy volunteers: Children aged 6-12 years who were born >37 weeks gestation who have no recurrent respiratory symptoms.
排除标准
- •Severe congenital abnormalities
- •Severe cardiopulmonary defects
- •Severe neurodevelopmental impairment
- •Glucocorticoid use within the past 3 months
研究者
相似试验
尚未招募
不适用
Corticosteroids for patients with acute respiratory distress syndrome; systematic review and meta-analysis.Acute respiratory distress syndromeJPRN-UMIN000041007JA General Hospital.
进行中（未招募）
1 期
Treating COVID-19 infections with inhaled corticosteroidsCOVID 19EUCTR2020-001889-10-GBniversity of Oxford, Clinical Trials and Research Governance478
招募中
1 期
Effect of Corton on olfactory dysfunction in COVID-19 patientsAnosmiaIRCT20200522047542N1Mashhad University of Medical Sciences70
招募中
不适用
Effect of inhaled corticosteroid therapy in pulmonary sarcoidosis patients who manifest airflow limitatioJPRN-UMIN000013831Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan40
进行中（未招募）
1 期
treatment with inhaled corticoids in patients with covid-19 and pneumoniaCOVID19MedDRA version: 20.0Level: LLTClassification code 10051905Term: Coronavirus infectionSystem Organ Class: 100000004862EUCTR2020-001616-18-ESFundació Clinic per a la Recerca Biomèdica300